Today on DrugResearcher.com
 
How does HIV cause AIDS?

Merck bulks up cardiovascular pipeline

MDS Pharma expands services in EU market

HIV therapy leads way in personalised medicine

PADI dives into the chemical analysis of solids

 
   
Related Industry News
 
Lonza pushes biopharma portfolio

Illuminating the future of drug delivery

Kendle's Charles River Labs buyout clouds Q2

Latest twists and turns in Inyx saga

 
 

Drug discovery

Breaking News on Drug Discovery
Daily  Thursday 02 August 2007 Forward to a colleague

Sponsored Message

BionasLive cell-based assay with Bionas® 2500 analyzing system

Bionas® 2500 measures multiple metabolic parameters simultaneously like acidification, oxygen consumption and adhesion of living cells. Metabolic and cytotoxic effects can be visualized as changes of these parameters in dependence of test compounds... Click Here


Access Full Stories



How does HIV cause AIDS?
Remarkably, despite being over 25 years into the HIV/AIDS epidemic, scientists still don't have an answer to the seemingly simple question: how does HIV cause AIDS?... Read


Merck bulks up cardiovascular pipeline
Merck & Co. is to bolster its late-stage cardiovascular pipeline through the acquisition of US-based pharma company NovaCardia... Read


MDS Pharma expands services in EU market
MDS Pharma Services has announced it is expanding its development and regulatory services (DRS) business in Europe while its bioanalytical operations are still struggling.  ... Read


HIV therapy leads way in personalised medicine
GlaxoSmithKline (GSK) has opened the flood gates into the world of personalised medicine with the world's first ever approved genetic test, which predicts a life threatening side effect of one of its antiretroviral... Read


PADI dives into the chemical analysis of solids
UK researchers have developed a new way to make compounds fly into a mass spectrometer (MS) that could provide benefits for researchers working in drug discovery and quality control (QC) laboratories... Read


All News Headlines for:
August | July | June

DrugResearcherProduct Overview

A revolution in Sales Lead Generation! - Free Download

Promote your products and technology towards our readers, and we'll build a detailed profile of each person who reads your presentation document... Download our FREE Smart Lead Generation brochure now!... Click Here
Related Industry News



Lonza pushes biopharma portfolio
Switzerland-based Lonza is establishing its biopharma portfolio with the acquisition of Zyentia's Aggresolve technology this week... Read


Illuminating the future of drug delivery
Irish researchers have developed a technique that could be used to deliver controlled amounts of drugs to diseased tissues while minimising side effects simply by shining light on the target... Read


Kendle's Charles River Labs buyout clouds Q2
A charge due to the acquisition of a Charles River Laboratories' unit a year ago has put a cloud on Kendle's Q2 otherwise all-time high performance... Read


Latest twists and turns in Inyx saga
The latest twists and turns in the Inyx Inc. bankruptcy saga include an attempted power seize by its creditor, fraud allegations thrown around courtrooms and in the media, the resignation of Inyx' accountants,... Read

Outsourcing-Pharma.com special focus

Latest twists and turns in Inyx saga

The latest twists and turns in the Inyx Inc. bankruptcy saga include an attempted power seize by its creditor, fraud allegations thrown around courtrooms and in the media, the resignation of Inyx' accountants, and increasing signs of links between Inyx and a company called Karver. Read



Sponsored Message

Discover our New Alert Service

DrugResearcher has launched a New Alert service on product and market innovation. To indicate your research interests and to subscribe to our FREE alerts,... Click Here

Previous Headlines



Drugs moving into the clinic: 23
The latest in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators... Read


Johnson & Johnson slashes jobs, closes facilities
Johnson & Johnson (J&J) has become the latest big pharma player to cut jobs and close facilities, in another example of the changing face of the industry landscape... Read


Teaching computers to read chemical structures
German scientists have developed software that can recognise chemical structure images and convert them into a computer readable format to enable graphical searching of patents and scientific papers... Read


Tepnel to launch new molecular services
Tepnel Research Products & Services has indicated it will soon begin offering a number of new molecular services at its new facility in Livingston, Scotland... Read


Gene therapy skies grey again
Just as the biopharma industry was recovering from its hangover after negative clinical events in the gene therapy field, the death of a patient during a gene therapy trial last week puts a cloud in the sky for... Read

Product Innovation Alerts - Free of Charge
Indicate your research interests and receive alerts on relevant products and market innovations
Analysis and instrumentation
Assays and screening
Cell culture & Equipment
Chromatography
Compounds and consumables
Contract services (outsourcing)
Drug discovery
Genomics / Proteomics
Informatics & IT
Lab equipment & consumables
Liquid handling and automation
Liquid handling and sample preparation
Production technologies
Separation and purification




Free Newsletters for Pharmaceuticals
Access now !Choose from over 20 industry e-newsletters
Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here

Forward to a colleague

To continue to receive this newsletter in your inbox, please add
newsletter@DrugResearcher.com to your address book

Update preferences | Change your email address | Unsubscribe

Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback

© 2007 - Decision News Media S.A.S - All Rights Reserved
La Tour du Triangle - 26, allee Jules Milhau - 34000 Montpellier - France
http://www.decisionnewsmedia.com